Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 15 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 9 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 1
10(71.4%)
Phase 2
2(14.3%)
N/A
2(14.3%)
14Total
Phase 1(10)
Phase 2(2)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (15)

Showing 15 of 15 trials
NCT04483115Phase 2Completed

Acute Haemodynamic Study of TPN171H in Patients with Pulmonary Arterial Hypertension

Role: collaborator

NCT05208814Phase 1Completed

A Study to Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients with Renal Insufficiency and Healthy Subjects

Role: collaborator

NCT06708780Phase 1Recruiting

Immunotherapy with Autologous Tregs in T1DM

Role: collaborator

NCT06186427Not ApplicableUnknown

A Novel 68Ga Labeled FAP Ligand PET/CT in Patients With Various Malignant Tumors

Role: collaborator

NCT05948644Phase 1Completed

The Safety, Tolerability, and Pharmacokinetics of TPN171H Tablets in Patients With Pulmonary Arterial Hypertension

Role: collaborator

NCT04479917Phase 2Completed

Efficacy and Safety of TPN171H in the Patients With Erectile Dysfunction

Role: collaborator

NCT05538819Completed

The Effects of Glimepiride in Patients With Type 2 Diabetes and Chronic Heart Failure

Role: collaborator

NCT05185011Phase 1Completed

Study of the Pharmacokinetics and Safety of TPN171H Tablets in Subjects With Mild ,Moderate Hepatic Insufficiency and Normal Liver Function

Role: collaborator

NCT03670173Phase 1Unknown

Safety and Efficacy Assessments of Osalmid in Multiple Myeloma

Role: collaborator

NCT04655872Phase 1Completed

Mass Balance of Oral [14C]TPN171H in Healthy Male Subjects

Role: collaborator

NCT03618602Phase 1Unknown

Safety, Pharmacokinetics and Efficacy Study of Bisthianostat in Refractory or Recurrent Multiple Myeloma Patients

Role: collaborator

NCT03568799Not ApplicableUnknown

4-[18F]Fluoroglutamine PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules

Role: collaborator

NCT03260179Phase 1Unknown

Study to Evaluate the Safety, Preliminary Efficacy and Pharmacokinetics of 3810

Role: collaborator

NCT03117101Phase 1Completed

Study of the AL3810 in the Treatment of Advanced Solid Tumor

Role: collaborator

NCT01832298Phase 1Completed

Study of Simmitecan Hydrochloride in the Treatment of Advanced Solid Tumor

Role: collaborator

All 15 trials loaded